Delivery Order SPE2DB22D9112-SPE2DB25FTKLS

Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,407.12 contract is to provide 4,564,856,921 units of Terbinafine HCl 250 mg tablets. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue firm...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4,568,168,535 units of Terbinafine Hydrochloride 250 mg tablets. The $2,111.04 firm-fixed-price delivery order has a completion date of May 6, 2025 and is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with DLA under the SPE2DB program. This IDC enables DLA to issue delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $1,407.12 contract is for the delivery of 4,564,928,264 tablets of the prescription drug terbinafine hydrochloride 250 mg, with a performance period through May 17, 2024. The award is under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical valued at up to $499,999,999. This IDC, part of the DLA's SPE2DB program, allows the...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,111.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 with DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical products, including branded and generic prescription...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,263,312 units of Terbinafine HCL 250 mg tablets in 100-count packages, with a total ceiling value of $8,183.04. The contract is a Firm Fixed Price arrangement with a performance period extending through May 16, 2025. This delivery order is part of a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,464.60, is for the supply of TERBINAFINE CREAM HCL, a pharmaceutical product. The contract has a firm fixed-price pricing structure and an ultimate completion date of August 28, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The $1,423.89 order is for the supply of Terbinafine Cream HCL, a topical antifungal medication. DMS Pharmaceutical Group holds multiple contracts and indefinite delivery vehicles with DLA to provide a variety of pharmaceutical and medical products to military treatment facilities worldwide. This specific delivery order is...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,505.00, is for the delivery of Terbinafine cream, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a larger, single-award indefinite delivery contract (IDC) with...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $1,254.62, is for the delivery of Terbinafine cream to support the recurring medical supply needs of military health facilities. The contract, a firm fixed-price delivery order (SPE2DX23FTRNV) under the Defense Logistics Agency's (DLA) Medical Supply Chain program, has an ultimate completion date of August 14, 2023. DMS...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,212,718 units of Terbinafine HCL 250 MG Tablets in 30-count packages, with a firm fixed price of $17,710.07 and a completion date of May 13, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D9112
    Indefinite Delivery Contract
  • SPE2DB22D9112-SPE2DB25FTKLS
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of 4,567,989,729 units of Terbinafine HCL 250 mg tablets in 30-count packages. The contract has a ceiling value of $1,055.34 and an ultimate completion date of April 23, 2025. It is a firm fixed-price contract with no set-aside designation. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide.

Generated 7/22/25, 9:56 AM